The Prima System is intended to partially replace the normal physiological function of the eyes photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve.

Home Institution

• Stanford University

  Stanford, CA, USA

Commercial Partners

• Pixium Vision

  Paris, France

• Science Corporation

  Alameda, CA, USA

Milestones

• 2023: FDA approval

Device Specifications

• Number of electrodes: 378

Clinical Trials

• NCT03333954
• NCT03392324